<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-133162</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Results of the Gynecologic Imaging Reporting and Data System classification in adnexal masses</dc:title>
<dc:description xml:lang="en">Objective. To assess the clinical usefulness of the Gynecologic Imaging Reporting and Data System (GI-RADS) classification to distinguish between benign and malignant adnexal masses. Material and methods. A retrospective study was conducted in 98 adnexal masses in 87 patients who underwent surgery in our hospital. The masses were classified according to GI-RADS and the results were compared with their definitive histologic diagnosis. Results. Seventy-five masses were classified as GI-RADS 3. All GI-RADS 3 masses had a definitive histologic diagnosis of benignity. Eleven masses were GI-RADS 4, of which 27.27% had a definitive histologic diagnosis of malignancy (one carcinoma and 2 borderline tumors) and 72.72% were diagnosed as benign. Twelve masses were GI-RADS 5, of which 91.66% had a definitive histologic diagnosis of malignancy (10 carcinomas and one borderline tumor). Discussion. Our results support the reliability of the GI-RADS classification to correctly identify malignant tumors in GI-RADS 4 and 5 (AU)</dc:description>
<dc:creator>Rams, Noelia</dc:creator>
<dc:creator>Muñoz, Raquel</dc:creator>
<dc:creator>Soler, Cristina</dc:creator>
<dc:creator>Parra, Juan</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Determinar el valor de la clasificación Gynecologic Imaging Reporting and Data System (GI-RADS) para discriminar las masas anexiales malignas de las benignas. Material y métodos. Estudio observacional retrospectivo de 87 pacientes operadas en nuestro hospital con un total de 98 masas anexiales. Se clasificaron mediante el sistema GI-RADS y se compararon con la histología definitiva. Resultados. GI-RADS 3: 75 casos. En todos los casos GI-RADS 3, el diagnóstico definitivo fue de benignidad. GI-RADS 4: 11 casos. En el 27,27% de los casos el diagnóstico definitivo fue de malignidad (un carcinoma y 2 tumores borderline), y en el 72,72% de los casos, de benignidad. GI-RADS 5: 12 casos. En el 91,66% de los casos el diagnóstico histológico informó de malignidad (10 carcinomas y un tumor borderline). Discusión. Nuestros resultados refuerzan la fiabilidad de la clasificación para catalogar correctamente las tumoraciones malignas en los grupos GI-RADS 4 y 5 (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);58(3): 125-129, mar. 2015. tab, ilus</dc:source>
<dc:identifier>ibc-133162</dc:identifier>
<dc:title xml:lang="es">Resultados de la clasificación Gynecologic Imaging Reporting and Data System para la catalogación de masas anexiales</dc:title>
<dc:subject>^d31276^s22016</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d2334^s29166</dc:subject>
<dc:subject>^d31276^s22009</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d2334^s22011</dc:subject>
<dc:subject>^d3556^s22011</dc:subject>
<dc:subject>^d31276^s22011</dc:subject>
<dc:subject>^d3556^s29166</dc:subject>
<dc:subject>^d31584^s22012</dc:subject>
<dc:subject>^d31276^s22032</dc:subject>
<dc:subject>^d31276^s29166</dc:subject>
<dc:subject>^d31584^s22011</dc:subject>
<dc:type>article</dc:type>
<dc:date>201503</dc:date>
</metadata>
</record>
</ibecs-document>
